Immunocytochemistry demonstrated expression of both GFAP (used as a marker of differentiated glioma cells) (Fig 1a) and P2X7R (Fig 1b) with co-expression of these markers demonstrated throughout the cell (Fig 1c). The gene discussed is GFAP; the disease is central nervous system cancer.